This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Surgical

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Surgical management should be considered where there is failure of medical management, particularly where this results in growth failure.

There is evidence to suggest that appropriate early surgery results in reduced symptoms and increased growth.

NICE have stated that surgery in Crohn's disease may be indicated if the disease is limited to the distal ileum. Also balloon dilatation may be indicated (2)

  • Crohn's disease limited to the distal ileum

    • surgery as an alternative to medical treatment
      • consider surgery as an alternative to medical treatment early in the course of the disease for people whose disease is limited to the distal ileum, taking into account the following:
        • benefits and risks of medical treatment and surgery
        • risk of recurrence after surgery
        • individual preferences and any personal or cultural considerations

    • surgery early in the disease
      • consider surgery early in the course of the disease or before or early in puberty for children and young people whose disease is limited to the distal ileum and who have:
        • growth impairment despite optimal medical treatmentand/or
        • refractory disease

  • balloon dilation
    • consider balloon dilation particularly in people with a single stricture that is short, straight and accessible by colonoscopy.

 

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.